Exodus Point Capital Management, LP Abb Vie Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 19,271 shares of ABBV stock, worth $3.89 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,271
Previous 1,600
1104.44%
Holding current value
$3.89 Million
Previous $316,000
983.54%
% of portfolio
0.02%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ABBV
# of Institutions
4,095Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.5 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.02 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $357B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...